UniCredit Bonus Zert NDA 27.09.20.../ DE000HC9KSY0 /
16/05/2024 10:33:00 | Diferencia+0.24 | Bid11:53:07 | Ask11:53:07 | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
78.31EUR | +0.31% | 78.31 Volumen de oferta: 1,000 |
78.40 Tamaño/ Volumen/ Formato de Ask: 1,000 |
AURUBIS AG | - EUR | 27/09/2024 | Call |
GlobeNewswire
12:00
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combinatio...
GlobeNewswire
12:00
Xunlei Announces Unaudited Financial Results for the First Quarter Ended March 31, 2024
GlobeNewswire
12:00
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainl...
GlobeNewswire
12:00
LANZATECH ALERT: Bragar Eagel & Squire, P.C. Investigates De-SPAC Merger of LNZA and AMCI and Encour...
GlobeNewswire
12:00
SHIMMICK ALERT: Bragar Eagel & Squire, P.C. is Investigating Shimmick Corporation on Behalf of Shimm...
GlobeNewswire
12:00
INOTIV ALERT: Bragar Eagel & Squire, P.C. is Investigating Inotiv, Inc. on Behalf of Inotiv Stockhol...
GlobeNewswire
12:00
FUTUREFUEL ALERT: Bragar Eagel & Squire, P.C. is Investigating FutureFuel Corp. on Behalf of FutureF...
GlobeNewswire
12:00
South Rampart Pharma Publishes SRP-001's Unique Pain Relief Mechanism and Phase 1 Trial Results in S...
GlobeNewswire
12:00
More Viewers are Trading Down to Ad-supported TV, Propelling Growth for SVOD Ad-tiers and FAST Platf...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página